Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopes
- PMID: 11980990
- DOI: 10.1200/JCO.2002.20.9.2217
Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopes
Comment on
-
ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial.J Clin Oncol. 2002 May 1;20(9):2240-50. doi: 10.1200/JCO.2002.10.112. J Clin Oncol. 2002. PMID: 11980995 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
